Global Cell Therapy Market Report and Forecast 2024-2032

Global Cell Therapy Market Trends

Increased Merger and Acquisition Activities to Meet Rising Market Demand

The market is witnessing increased merger and acquisition initiatives to pool resources and expertise in order to expedite the development of novel cell therapies. For instance, in April 2024, the biotechnology company Century Therapeutics acquired United States-based cell therapy company Clade Therapeutics, Inc., in a deal that requires Century to pay USD 35 million upfront and an additional USD 10 million as milestone payments. The biotech firm plans to leverage this acquisition to expand its pipeline of autoimmune and cancer therapies. It gains ownership of Clade’s three preclinical allogeneic induced pluripotent stem cell (iPSC)-derived cell candidates including CLDE-308 (a CD19 targeting αβ iT cell programme for treating B-cell malignancies and autoimmune diseases), CLDE-361 (a B-cell maturation antigen (BCMA) αβ iT cell programme for the treatment of myasthenia gravis), and an undisclosed candidate for solid tumors treatment along with its αβ iT platform. Such strategic partnerships that acquire promising clinical candidates in different disease indications are expected to elevate the cell therapy market value.

Surge in Demand for CAR T-Cell Therapy Drives Market Growth

Chimeric Antigen Receptor (CAR) T-cell therapy is a type of cellular immunotherapy that has emerged as a breakthrough in cancer treatment. This cell-based gene therapy has shown positive results in treating certain types of blood cancers, such as leukemia and lymphoma. The high efficacy of CAR T-cell therapy especially in patients who were not responding to other standard treatments has augmented the interest and demand for this new treatment, which influences the dynamics of the cell therapy market.

In April 2024, the Indian president launched the first indigenously developed CAR T-cell therapy to treat cancer, created by the Indian Institute of Technology (IIT) Bombay and Tata Memorial Centre, as part of the Make in India initiative. It was reported that this indigenously developed cancer treatment NexCAR19 CAR T-cell therapy is one-tenth of its price outside the country, with the therapy cost amounting to roughly INR 4 crore abroad to INR 30 lakh in India. The lower cost of the treatment is a significant milestone in the healthcare sector, making CAR-T cell therapy affordable and more accessible to the growing patient pool. Thus, increased government support to advance cell therapy innovations is projected to bolster market growth in the coming years.

Rising Equity Investments to Support the Development of Novel Cell Therapy Products Elevates Market Value

One of the major market trends is the increased equity investments to propel the development of novel cell therapy products. Substantial investments drive intensive research and development (R&D) activities, preclinical studies, and the advancement of potential therapies into clinical trials. Adequate funding also ensures that innovative cell therapies secure regulatory approval and gain market access, which contributes to the growing share of the cell therapy market.

Following the equity investment and research partnership agreement in November 2023, multinational pharmaceutical and biotechnology company AstraZeneca concluded an equity investment in Cellectis, a clinical-stage biopharmaceutical company focused on developing the Next-Generation CAR T-Cells to cure cancer, in May 2024. Under the agreement, the biotech firms plan to develop up to ten novel cell and gene therapy products in areas of high unmet medical needs such as oncology, immunology, and rare diseases, by employing Cellectis’ gene editing technologies and manufacturing expertise. As part of this research partnership deal, Cellectis received USD 105 million as an initial payment from AstraZeneca in Q4 2023. The rising equity investments in the cell therapy sector is likely to boost the market share in the forecast period.

Cell Therapy Market Report Snapshots

Cell Therapy Market Size

Cell Therapy Market Trends

Cell Therapy Market Share

Cell Therapy Companies